NO996132D0 - Vaccine compositions comprising Heliobacter Pylori FlgE polypeptides - Google Patents

Vaccine compositions comprising Heliobacter Pylori FlgE polypeptides

Info

Publication number
NO996132D0
NO996132D0 NO996132A NO996132A NO996132D0 NO 996132 D0 NO996132 D0 NO 996132D0 NO 996132 A NO996132 A NO 996132A NO 996132 A NO996132 A NO 996132A NO 996132 D0 NO996132 D0 NO 996132D0
Authority
NO
Norway
Prior art keywords
polypeptides
vaccine compositions
heliobacter pylori
pylori flge
flge
Prior art date
Application number
NO996132A
Other languages
Norwegian (no)
Other versions
NO996132L (en
Inventor
Thomas Berglindh
Bjoern Mellgord
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO996132D0 publication Critical patent/NO996132D0/en
Publication of NO996132L publication Critical patent/NO996132L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO996132A 1997-06-12 1999-12-10 Vaccine compositions comprising Heliobacter pylori FlgE polypeptide NO996132L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702242A SE9702242D0 (en) 1997-06-12 1997-06-12 Vaccine compositions V
PCT/SE1998/001093 WO1998056816A1 (en) 1997-06-12 1998-06-08 VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI FlgE POLYPEPTIDE

Publications (2)

Publication Number Publication Date
NO996132D0 true NO996132D0 (en) 1999-12-10
NO996132L NO996132L (en) 2000-01-28

Family

ID=20407351

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996132A NO996132L (en) 1997-06-12 1999-12-10 Vaccine compositions comprising Heliobacter pylori FlgE polypeptide

Country Status (21)

Country Link
EP (1) EP1009764A1 (en)
JP (1) JP2002507118A (en)
KR (1) KR20010013699A (en)
CN (1) CN1259960A (en)
AR (1) AR012896A1 (en)
AU (1) AU8048798A (en)
BR (1) BR9810026A (en)
CA (1) CA2293293A1 (en)
EE (1) EE9900566A (en)
HU (1) HUP0003164A3 (en)
ID (1) ID23052A (en)
IL (1) IL133144A0 (en)
IS (1) IS5288A (en)
NO (1) NO996132L (en)
NZ (1) NZ501427A (en)
PL (1) PL337503A1 (en)
SE (1) SE9702242D0 (en)
SK (1) SK173099A3 (en)
TR (1) TR199903060T2 (en)
WO (1) WO1998056816A1 (en)
ZA (1) ZA984696B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104784687A (en) * 2015-04-27 2015-07-22 苏州大学附属第一医院 Application of flagellar hook protein FlgE of reorganized pseudomonas aeruginosa
CN113425717B (en) * 2021-04-22 2023-06-16 成都欧林生物科技股份有限公司 Medicament for improving efficacy of oral helicobacter pylori vaccine and application thereof
CN116535472B (en) * 2023-05-31 2024-04-30 四川大学华西医院 Helicobacter pylori recombinant protein antigen FlgK and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459041A (en) * 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
AR003125A1 (en) * 1995-06-01 1998-07-08 Astra Ab BACTERIAL ANTIGENS FOR THE DIAGNOSIS OF INFECTIONS WITH HELICOBACTER PYLORI, A DNA MOLECLE THAT CODES IT, A VECTOR, A HOST CELL, A PROCEDURE FOR PRODUCING THE POLIPEPTIDE, USE OF ELEPIPETICO, AND PROAPILY USE

Also Published As

Publication number Publication date
BR9810026A (en) 2000-09-19
ID23052A (en) 2000-01-20
HUP0003164A3 (en) 2001-10-29
SK173099A3 (en) 2000-06-12
ZA984696B (en) 1999-01-04
PL337503A1 (en) 2000-08-28
AU8048798A (en) 1998-12-30
HUP0003164A2 (en) 2000-12-28
SE9702242D0 (en) 1997-06-12
EP1009764A1 (en) 2000-06-21
CN1259960A (en) 2000-07-12
IS5288A (en) 1999-12-08
KR20010013699A (en) 2001-02-26
WO1998056816A1 (en) 1998-12-17
JP2002507118A (en) 2002-03-05
EE9900566A (en) 2000-06-15
NO996132L (en) 2000-01-28
IL133144A0 (en) 2001-03-19
AR012896A1 (en) 2000-11-22
TR199903060T2 (en) 2000-09-21
CA2293293A1 (en) 1998-12-17
NZ501427A (en) 2000-09-29

Similar Documents

Publication Publication Date Title
DK0998272T3 (en) Pharmaceutical preparation for the combination piperidinoalkanol decongestant
NO20012636D0 (en) Controlled release formulation comprising GNRH-II
BR9710053A (en) Pesticide compositions
ATE242971T1 (en) PESTICIDE COMPOSITIONS
ID17241A (en) PESTICIDE COMPOSITIONS
DE69736679D1 (en) FLOWABLE FAT COMPOSITION
DE69828330D1 (en) Activated Protein C Formulations
ID20005A (en) PESTICIDE COMPOSITION
IS5046A (en) pharmaceutical compositions
NO20001914D0 (en) <alfa> -Aryl-N-alkylnitrons and pharmaceutical compositions containing them
CY2006006I1 (en) PROTEIN FORMULATIONS
ATE245356T1 (en) PESTICIDE COMPOSITIONS
DK1023035T3 (en) The oral composition
DK1109450T3 (en) The microcapsule preparations
DK0940712T3 (en) Projection cream
ID23772A (en) COMPOSITIONS THROUGH THE MOUTH
PT969815E (en) PHARMACEUTICAL COMPOSITIONS
ID30032A (en) PHARMACEUTICAL FORMULATION
DE69815138D1 (en) Phosphonium COMPOSITION
NO996132D0 (en) Vaccine compositions comprising Heliobacter Pylori FlgE polypeptides
DE60000808D1 (en) Flowable pesticide oil-in-water formulations
EE200000459A (en) Pharmaceutical compositions
ID16820A (en) PESTICIDE COMPOSITIONS
AU7945798A (en) Vaccine compositions comprising the (helicobacter pylori) 26kda polypeptide
DE29722888U1 (en) Packing star

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application